We are live on
!
Find out more
Point72 Asset Management Portfolio holdings
AUM
$78.1B
1-Year Est. Return
55.25%
This Fund
S&P 500
This Quarter
Est. Return
+7.15%
1 Year Est. Return
+55.25%
3 Year Est. Return
+151.79%
5 Year Est. Return
+188.05%
10 Year Est. Return
+800.63%
AUM
$22.3B
AUM Growth
+$851M
(+4%)
Cap. Flow
-$176M
Cap. Flow
% of AUM
-0.79%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
1,274
New
347
Increased
260
Reduced
248
Closed
334
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$372M |
| 2 |
Amazon
AMZN
|
+$228M |
| 3 |
Analog Devices
ADI
|
+$121M |
| 4 |
United Therapeutics
UTHR
|
+$105M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$97.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$238M |
| 2 |
DXC Technology
DXC
|
+$235M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$183M |
| 4 |
NXP Semiconductors
NXPI
|
+$158M |
| 5 |
Baidu
BIDU
|
+$154M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.55% |
| 2 | Healthcare | 19.74% |
| 3 | Consumer Discretionary | 12.58% |
| 4 | Financials | 7.27% |
| 5 | Communication Services | 6.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNVY
551
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
| $6.45M | 0.03% |
+566,819
| New | +$6.56M |
|
|
MAXR
552
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $6.42M | 0.03% |
160,900
-25,800
| -14% | -$919K |
|
553
Under Armour Class C
UA
$2.78B
| $6.41M | 0.03% |
345,300
+188,000
| +120% | +$3.54M |
|
554
Zumiez
ZUMZ
$330M
| $6.38M | 0.03% |
130,200
+127,500
| +4,722% | +$5.72M |
|
555
FTC Solar
FTCI
$42.7M
| $6.37M | 0.03% |
+47,832
| New | +$5.35M |
|
|
MODV
556
DELISTED
ModivCare
MODV
| $6.36M | 0.03% |
37,400
-26,900
| -42% | -$4.03M |
|
557
Regenxbio
RGNX
$624M
| $6.36M | 0.03% |
163,608
-742,692
| -82% | -$26.6M |
|
558
Commault Systems
CVLT
$4.79B
| $6.35M | 0.03% |
+81,288
| New | +$5.91M |
|
559
Century Aluminum
CENX
$4.43B
| $6.33M | 0.03% |
+491,400
| New | +$7.08M |
|
560
C4 Therapeutics
CCCC
$387M
| $6.27M | 0.03% |
+165,600
| New | +$5.93M |
|
|
TGNA
561
DELISTED
TEGNA Inc
TGNA
| $6.26M | 0.03% |
+333,634
| New | +$6.55M |
|
562
CALL
Levi Strauss
LEVI
$9.52B
| $6.24M | 0.03% |
+225,000
| New | +$6.18M |
|
563
CALL
Mercado Libre
MELI
$95.6B
| $6.23M | 0.03% |
+4,000
| New | +$5.87M |
|
564
Relmada Therapeutics
RLMD
$548M
| $6.23M | 0.03% |
194,510
+22,010
| +13% | +$764K |
|
565
Alto Ingredients
ALTO
$366M
| $6.2M | 0.03% |
+1,014,686
| New | +$5.9M |
|
566
Replimune Group
REPL
$902M
| $6.2M | 0.03% |
161,300
-453,978
| -74% | -$15.5M |
|
567
OrthoPediatrics
KIDS
$512M
| $6.2M | 0.03% |
98,075
+57,541
| +142% | +$3.31M |
|
568
Royal Caribbean
RCL
$85.6B
| $6.14M | 0.03% |
71,988
-161,871
| -69% | -$14.1M |
|
569
Option Care Health
OPCH
$3.42B
| $6.12M | 0.03% |
+280,000
| New | +$5.4M |
|
570
Revolution Medicines
RVMD
$40.1B
| $6.11M | 0.03% |
+192,600
| New | +$6.72M |
|
|
DCPH
571
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $6.08M | 0.03% |
+166,100
| New | +$6.43M |
|
|
AZRE
572
DELISTED
Azure Power Global Limited
AZRE
| $6.05M | 0.03% |
224,867
+113,667
| +102% | +$2.64M |
|
573
Haemonetics
HAE
$3.84B
| $6.04M | 0.03% |
90,600
-99,100
| -52% | -$7.01M |
|
574
Carrier Global
CARR
$51.2B
| $6.02M | 0.03% |
123,900
-7,257
| -6% | -$324K |
|
575
Bloomin' Brands
BLMN
$738M
| $6.01M | 0.03% |
+221,446
| New | +$6.27M |
|
Similar funds
CBU
BC
Point72 Asset Management's Q2 2021 Portfolio in Review
As of Q2 2021, Point72 Asset Management held 1,274 positions worth $22.3B, up 4% from $21.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Point72 Asset Management's Q2 2021 filing shows 347 new, 260 increased, 248 reduced and 334 closed positions. Its largest new stake was United Therapeutics: 552,400 shares worth $99.1M. The largest sale was Applied Materials, an estimated $238M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Point72 Asset Management's largest Q2 2021 buy was United Therapeutics: 552,400 shares worth $99.1M.
- Point72 Asset Management added most to Salesforce in Q2 2021, an estimated $372M increase.
- Point72 Asset Management's biggest Q2 2021 reduction was Applied Materials, cutting an estimated $238M.
- Point72 Asset Management fully exited DXC Technology in Q2 2021, selling an estimated $235M.
- Point72 Asset Management's ten largest holdings make up 18% of its $22.3B portfolio in Q2 2021.
- Point72 Asset Management opened 347 new positions and closed 334 in Q2 2021.
- Point72 Asset Management's portfolio value rose 4% quarter-over-quarter to $22.3B.
Based on Point72 Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.